Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
34,209,159
-
Share change
-
-4,890,941
-
Total reported value
-
$94,398,783
-
Put/Call ratio
-
139%
-
Price per share
-
$2.76
-
Number of holders
-
73
-
Value change
-
-$12,856,779
-
Number of buys
-
33
-
Number of sells
-
29
Institutional Holders of STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) as of Q1 2021
As of 31 Mar 2021,
STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,209,159 shares.
The largest 10 holders included
CAXTON CORP, NEA Management Company, LLC, MORGAN STANLEY, VANGUARD GROUP INC, BlackRock Inc., AIGH Capital Management LLC, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Ikarian Capital, LLC, and Hudson Bay Capital Management LP.
This page lists
73
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.